Eton Pharmaceuticals, Inc.

ETON· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$45.14-2.76%

2026-08-03

Financials

Valuation Metrics

Eton Pharmaceuticals, Inc.'s Market Cap is $1.24B. At end of 2025 it was $455M. Ranked #2372 of 3,112 in US market (top 76%), #953 of 1,445 on NASDAQ (top 66%), #174 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 65%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.24B	US#2,372/3,112 Sec#174/269
Revenue	$87M	US#2,810/3,112 Sec#133/269
Net Income	$-1M	US—/3,112 Sec—/269
Total Assets	$98M	US#3,039/3,112 Sec#265/269
Net Assets	$31M	US#2,962/3,112 Sec#248/269
Value
P/B	40.39x	US#2,913/3,112 Sec#246/269
P/S	14.22x	US#2,746/3,112 Sec#134/269
EV/EBITDA	225.35x	US#2,480/3,112 Sec#88/269
FCF Yield	1.25%	US#2,098/3,112 Sec#74/269
Profitability
ROE	-4.82%	US#2,308/3,112 Sec#84/269
ROA	-1.51%	US#2,345/3,112 Sec#82/269
Op. Margin	2.35%	US#2,286/3,112 Sec#79/269
Revenue Growth	40.41%	US#372/3,112 Sec#61/269
Financial Health
Debt Ratio	219.16%	US#1,875/3,112 Sec#205/269
Total Debt	$12M	US#2,764/3,112 Sec#193/269
FCF	$15M	US#2,174/3,112 Sec#77/269
Cash	$20M	US#2,866/3,112 Sec#260/269
Current Ratio	1.21x	US#1,993/3,112 Sec#256/269
Net Debt/EBITDA	-1.36x	US#257/3,112 Sec#21/269
Performance
1Y Return	219.46%	US#92/3,112 Sec#28/269
1M Return	20.37%	US#138/3,112 Sec#8/269
From 52W High	-10.04%	US#1,047/3,112 Sec#53/269
1Y MDD	-36.17%	US#1,751/3,112 Sec#120/269
Trading
Volume	462,368 shares	US#2,128/3,112 Sec#208/269
Trading Value	$21M	US#1,937/3,112 Sec#143/269
Per Share
EPS	$-0.17	US—/3,112 Sec—/269
BPS	$0.97	US#2,625/3,112 Sec#202/269